Open Access

Glucagon-like peptide 1 receptor agonist use in cardiology.

Congress Session

About the speaker

Professor Mark Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
19 presentations
0 follower

3 more presentations in this session

Glucagon-like peptide 1 receptor agonists & cardiovascular outcomes: What have we learned?

Speaker: Doctor M. Cavender (Chapel Hill, US)

Thumbnail

Cardiovascular effects of glucagon-like peptide 1 receptor agonists.

Speaker: Doctor M. Husain (Toronto, CA)

Thumbnail

Live panel discussion.

Thumbnail

Access the full session

Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Speakers: Professor M. Petrie, Doctor M. Cavender, Doctor M. Husain
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Using a digital tool to solve organizational challenges in the Heart Failure team.

22 October 2021

Open Access

COVID-19 & digital health: techcelleration here to stay?

22 October 2021

Open Access

The ESC journey and future directions.

22 October 2021

This platform is supported by

logo Novo Nordisk